GlassScriptPhysician profile
Anna O Barton
NPI 1003135591
$3,430.56
in general payments reported to CMS, 2019-2025
28 companies · $99.49 in 2025
The $99.49 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $747 · 2022: $892 · 2023: $1,178 · 2024: $514 · 2025: $99.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $682.48 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $470.95 | 2021-2023 | |
| Organon LLC | $274.15 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $267.36 | 2021-2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $208.60 | 2021-2024 | Twirla |
| Pfizer INC. | $173.16 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $172.43 | 2023-2024 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $136.30 | 2022-2025 | Slynd |
| Biohaven Pharmaceuticals, INC. | $114.28 | 2021 | |
| Myovant Sciences INC. | $108.13 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.21 | 2021-2023 | |
| Coopersurgical, INC. | $96.66 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $92.89 | 2024-2025 | Veozah |
| Avion Pharmaceuticals | $85.96 | 2021-2023 | Balcoltra |
| Therapeuticsmd, INC. | $68.13 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $65.84 | 2022 | |
| Merck Sharp & Dohme LLC | $57.14 | 2021 | |
| Amgen INC. | $55.92 | 2021-2023 | Prolia, Evenity |
| Exact Sciences Corporation | $44.24 | 2023 | Cologuard Collection Kit |
| Ethicon US, LLC | $36.99 | 2022 | |
| Novo Nordisk INC | $17.72 | 2024 | Wegovy |
| Hologic Sales and Service, LLC | $17.51 | 2021 | |
| Becton, Dickinson and Company | $17.03 | 2021 | |
| Shield Therapeutics INC | $15.73 | 2022 | |
| Sage Therapeutics, LLC | $14.61 | 2021 | |
| Lupin INC. | $12.54 | 2021 | |
| Daiichi Sankyo INC. | $11.38 | 2021 | |
| Urovant Sciences INC | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.